Literature DB >> 10890625

Plasma redox status relates to severity in critically ill patients.

J M Alonso de Vega1, J Díaz, E Serrano, L F Carbonell.   

Abstract

OBJECTIVE: To determine the relation between plasma redox status and severity of illness for patients admitted to an intensive care unit (ICU).
DESIGN: A prospective cohort study.
SETTING: A mixed medical and surgical adult ICU with 12 beds. PATIENTS: A total of 73 consecutive patients admitted to the ICU.
INTERVENTIONS: Venous blood samples were routinely obtained within 24 hrs of admission.
MEASUREMENTS AND MAIN RESULTS: Plasma total antioxidant capacity and lipoperoxides were measured by spectrophotometric technique at admission to the ICU. The plasma ratio total antioxidant capacity (mM)/lipoperoxides (microM) was used as an index of plasma redox status. Plasma concentration of the markers of leukocyte activation myeloperoxidase (enzyme-linked immunosorbent assay) and polymorphonuclear-elastase (immunoactivation assay) were also measured at admission to the ICU. Analysis of correlation between plasma ratio total antioxidant capacity/lipoperoxides and APACHE III score showed a negative association (p < .001, Spearman correlation test). Myeloperoxidase and polymorphonuclear-elastase correlated positively with Acute Physiology and Chronic Health Evaluation III scores (r2 = 0.58; p < .001; and r2 = 0.05; p = .035; respectively).
CONCLUSIONS: Plasma redox status relates to severity in critically ill patients. We propose that it would be reasonable to provide antioxidant therapy as part of routine management of patients admitted to a mixed ICU, regardless of the specific reason for ICU admission. Plasma redox status might become useful to evaluate the risk in critically ill patients.

Entities:  

Mesh:

Year:  2000        PMID: 10890625     DOI: 10.1097/00003246-200006000-00021

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

1.  Sepsis: redox mechanisms and therapeutic opportunities.

Authors:  Shyam Biswal; Daniel G Remick
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

2.  Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients.

Authors:  Avery B Nathens; Margaret J Neff; Gregory J Jurkovich; Patricia Klotz; Katherine Farver; John T Ruzinski; Frank Radella; Iris Garcia; Ronald V Maier
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

3.  A forced titration study of the antioxidant and immunomodulatory effects of Ambrotose AO supplement.

Authors:  Stephen P Myers; Lesley Stevenson; Phillip A Cheras; Joan O'Connor; Lyndon Brooks; Margaret Rolfe; Paul Conellan; Carol Morris
Journal:  BMC Complement Altern Med       Date:  2010-04-30       Impact factor: 3.659

4.  Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-κB suppression.

Authors:  Rahul Checker; Raghavendra S Patwardhan; Deepak Sharma; Jisha Menon; Maikho Thoh; Santosh K Sandur; Krishna B Sainis; T B Poduval
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

5.  Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study.

Authors:  E J Giamarellos-Bourboulis; D Plachouras; A Tzivra; V Kousoulas; N Bolanos; M Raftogiannis; I Galani; I Dontas; A Dionyssiou-Asteriou; H Giamarellou
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

6.  Depletion of plasma antioxidants in surgical intensive care unit patients requiring parenteral feeding: effects of parenteral nutrition with or without alanyl-glutamine dipeptide supplementation.

Authors:  Menghua Luo; Concepcion Fernandez-Estivariz; Dean P Jones; Carolyn R Accardi; Birgit Alteheld; Niloofar Bazargan; Li Hao; Daniel P Griffith; Jeffrey B Blumberg; John R Galloway; Thomas R Ziegler
Journal:  Nutrition       Date:  2008-01       Impact factor: 4.008

7.  Urinary biomarker of oxidative stress correlating with outcome in critically septic patients.

Authors:  Wei-Erh Cheng; Chuen-Ming Shih; Liang-Wen Hang; Kuen-Yuh Wu; Hsin-Ling Yang; Wu-Huei Hsu; Te-Chun Hsia
Journal:  Intensive Care Med       Date:  2007-04-11       Impact factor: 17.440

8.  Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials.

Authors:  Mette M Berger; Philippe Eggimann; Daren K Heyland; René L Chioléro; Jean-Pierre Revelly; Andrew Day; Wassim Raffoul; Alan Shenkin
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  Injury severity and serum amyloid A correlate with plasma oxidation-reduction potential in multi-trauma patients: a retrospective analysis.

Authors:  Leonard T Rael; Raphael Bar-Or; Kristin Salottolo; Charles W Mains; Denetta S Slone; Patrick J Offner; David Bar-Or
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-11-19       Impact factor: 2.953

10.  Urinary biomarker of oxidative stress correlating with outcome in critically septic patients.

Authors:  Wei-Erh Cheng; Chuen-Ming Shih; Liang-Wen Hang; Kuen-Yuh Wu; Hsin-Ling Yang; Wu-Huei Hsu; Te-Chun Hsia
Journal:  Intensive Care Med       Date:  2007-06-05       Impact factor: 41.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.